Company Filing History:
Years Active: 2007-2018
Title: Innovations by Mark A Fauci
Introduction
Mark A Fauci is an accomplished inventor based in Patchogue, NY (US). He has made significant contributions to the field of medication adherence through his innovative systems and methods. With a total of five patents to his name, Fauci's work focuses on enhancing the safety and efficiency of drug delivery.
Latest Patents
One of Fauci's latest patents is centered around methods and systems to secure control and enhance medication adherence. This invention provides safe, secure, and accurate point-to-point delivery of both prescription and non-prescription drugs in long-term home care or ambulatory care environments. The system is designed to be low-cost and easy to use, featuring a secure drug dispensing unit and medication enclosure that incorporates wireless connectivity and software based on smart mobile phone technology. The Secure, Control, and Enhance Medication Adherence (SCEMA) system aims to mitigate risks associated with drug use, particularly for the elderly and the general public, without significantly increasing costs to the existing drug distribution infrastructure. Additionally, the SCEMA system serves as a powerful platform for drug research.
Career Highlights
Throughout his career, Fauci has worked with notable companies such as Gen9, Inc. and Advanced Biophotonics, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for medication management.
Collaborations
Fauci has collaborated with professionals like Matthew A Salvitti and Marek Pawlowski, further enhancing his work in the field of medication adherence.
Conclusion
Mark A Fauci's contributions to medication adherence through his innovative patents demonstrate his commitment to improving healthcare delivery. His work not only addresses critical issues in drug distribution but also paves the way for future advancements in the field.